Mitochondrial modulation with leriglitazone as a potential treatment for Rett syndrome

BACKGROUND: Rett syndrome is a neuropediatric disease occurring due to mutations in MECP2 and characterized by a regression in the neuronal development following a normal postnatal growth, which results in the loss of acquired capabilities such as speech or purposeful usage of hands. While altered n...

Descripción completa

Detalles Bibliográficos
Autores principales: Musokhranova, Uliana, Grau, Cristina, Vergara, Cristina, Rodríguez-Pascau, Laura, Xiol, Clara, Castells, Alba A., Alcántara, Soledad, Rodríguez-Pombo, Pilar, Pizcueta, Pilar, Martinell, Marc, García-Cazorla, Angels, Oyarzábal, Alfonso
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10601217/
https://www.ncbi.nlm.nih.gov/pubmed/37884937
http://dx.doi.org/10.1186/s12967-023-04622-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10601217/
https://www.ncbi.nlm.nih.gov/pubmed/37884937
http://dx.doi.org/10.1186/s12967-023-04622-5

Ejemplares similares